pyridoxal phosphate anhydrous
Pyridoxal phosphate (PLP, pyridoxal 5'-phosphate, P5P) is a coenzyme, the active form of vitamin B6. Pyridoxal 5′-phosphate (PLP) is used as a cofactor for a wide range of enzymes including mitochondrial cysteine desulfurase, cystathionine γ-synthase (CGS), ornithine 4,5-aminomutase (OAM), and d-serine dehydratase. The versatility of PLP arises from its ability to covalently bind the substrate, and then to act as an electrophilic catalyst, thereby stabilizing different types of carbanionic reaction intermediates. PLP acts as a coenzyme in all transamination reactions, in various beta-elimination reactions, in the condensation reaction in heme synthesis. — NCATS
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Earliest trial started Jan 1, 2019 (NCT04762316)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
SMILES
CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O- Mol. weight
- 247.1419 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSF06SGE49M6 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04706013 | Phase 3 | Oct 31, 2021 | Medicure |
| NCT04762316 | Phase 4 | Jan 1, 2019 | Triệu, Nguyễn Thị, M.D. |
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medicure | For profit | 1 | 1 | 1 | 2021 |
| Triệu, Nguyễn Thị, M.D. | Academic/Hospital | 1 | 1 | 1 | 2019 |